Compassionate-use programs usually mean the company got paid a lot; the wording just sounds nicer than admitting it is about money.
Eli Lilly granted a 79-year-old patient early access to an experimental obesity drug through the FDA compassionate-use program. The article suggests the person had unusual connections. Anyone heard more details?